# Radioactive Iodine Implants for Pan-invasive Pituitary Macroadenomas

> **NCT01444209** · PHASE2 · TERMINATED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 2 (actual)

## Conditions studied

- Pituitary Macroadenoma

## Interventions

- **RADIATION:** Iodine Implants

## Key facts

- **NCT ID:** NCT01444209
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-09-30
- **Primary completion:** 2020-10-20
- **Final completion:** 2021-01-20
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Failure to accrue
- **Last updated:** 2021-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01444209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01444209, "Radioactive Iodine Implants for Pan-invasive Pituitary Macroadenomas". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01444209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*